BARCLAYS PLC - HILLEVAX INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HILLEVAX INC
ValueSharesWeighting
Q3 2023$86
-15.7%
6,374
+6.3%
0.00%
Q2 2023$102
-30.6%
5,999
-32.4%
0.00%
Q1 2023$147
+86.1%
8,868
+89.2%
0.00%
Q4 2022$79
-99.1%
4,688
+753.9%
0.00%
Q3 2022$9,000
+28.6%
549
-15.5%
0.00%
Q2 2022$7,0006500.00%
Other shareholders
HILLEVAX INC shareholders Q4 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 558,923$7,517,5149.98%
Frazier Life Sciences Management, L.P. 9,781,472$131,560,7988.74%
Samsara BioCapital, LLC 799,274$10,750,2353.29%
VR Adviser, LLC 2,037,313$27,401,8602.88%
StepStone Group LP 826,567$11,117,3262.48%
ACUTA CAPITAL PARTNERS, LLC 270,319$3,635,7912.44%
Deep Track Capital, LP 2,900,000$39,005,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,004,231$53,856,9071.19%
Carlyle Group Inc. 1,838,486$24,690,8671.07%
Monashee Investment Management LLC 110,000$1,479,5000.62%
View complete list of HILLEVAX INC shareholders